Skip to content

Progress in Neuro-Psychopharmacology and Biological Psychiatry

ISSN 1878-4216, 0278-5846

154 papers in the library · 1,492 citations · publishing 1985-2026

Papers

Sort Most recent Most cited

Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 10, 2012 Evan J. Kyzar, Christopher Collins, Siddharth Gaikwad et al. 122 citations

Mescaline and phencyclidine (PCP) are potent hallucinogenic agents affecting human and animal behavior. As their psychotropic effects remain poorly understood, further research is necessary to characterize phenotypes they evoke in various animal models. Zebrafish (Danio rerio) are rapidly emerging as a new model organism for neuroscience research. Here, we examine the effects of mescaline...

The role of glutamate on the action of antidepressants.

Progress in Neuro-Psychopharmacology and Biological Psychiatry August 15, 2011 Kenji Hashimoto

Major depressive disorder (MDD) is a common, chronic, recurrent mental illness that affects millions of individuals worldwide. Currently available antidepressants are known to affect the monoaminergic (e.g., serotonin, norepinephrine, and dopamine) systems in the brain. Accumulating evidence suggests that the glutamatergic neurotransmission via the excitatory amino acid glutamate also plays an...

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 1, 2011 Lobna Ibrahim, Nancy Diazgranados, David A. Luckenbaugh et al.

Ketamine rapidly improves depressive symptoms in patients with treatment-resistant major depressive disorder (MDD) who do not respond to multiple standard antidepressants. However, it remains unknown whether ketamine is equally effective in patients with MDD who previously also did not respond to electroconvulsive therapy (ECT). This study compared 17 patients with treatment-resistant MDD who...

The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 15, 2011 Jaime E. C. Hallak, Serdar Dursun, Daniel C Bosi et al.

Interactions between glutamatergic and endocannabinoid systems may contribute to schizophrenia, dissociative states, and other psychiatric conditions. Cannabidiol (CBD), a cannabinoid-1/2 (CB1/2) receptor weak partial agonist or antagonist, may play a role in the treatment of schizophrenia. This study tested the hypothesis that CBD would attenuate the behavioral effects of the NMDA receptor...

Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition.

Progress in Neuro-Psychopharmacology and Biological Psychiatry May 30, 2010 Tomáš Páleníček, Zdenek Hlinák, Vĕra Bubeníková‐valešová et al.

The aim of this study was to describe sex differences in the behavioural effects of N,N-diethyllysergamide (LSD) (locomotor activity and other behavioural repertoire in the open field) and its effects on sensorimotor gating in rats (prepulse inhibition (PPI) of the acoustic startle reaction). Three groups of animals were analysed: males, oestral and pro-oestral phase females (EP females), and...

Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats.

Progress in Neuro-Psychopharmacology and Biological Psychiatry April 30, 2009 Lêda S B Garcia, Clarissa M Comim, Samira S Valvassori et al.

Several studies have supported the idea that ionotropic glutamate N-methyl-d-aspartate receptor (NMDA) is an important player in the etiology of psychopathologies, such as anxiety disorders and major depression. Additionally, studies have shown that ketamine induces antidepressant effects in humans as well as in rodents subjected to animal models of depression. In this context, the present...

Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.

Progress in Neuro-Psychopharmacology and Biological Psychiatry December 12, 2008 Sarah Durkin, Alison Prendergast, Andrew Harkin

Long-term serotonin (5-HT) neuronal loss is currently a major cause of concern associated with recreational use of the substituted amphetamine 3,4 methylenedioxymethamphetamine (MDMA; "Ecstasy"). Such loss may be problematic considering that psychiatric disorders such as depression and anxiety and responses to first line treatments for these disorders are associated with 5-HT. In this study the...

Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study.

Progress in Neuro-Psychopharmacology and Biological Psychiatry February 15, 2008 Mikhail Kalinichev, Melanie J Robbins, Elizabeth M Hartfield et al.

In a putative model of acute phencyclidine (PCP)-induced psychosis we evaluated effects of the drug on locomotor activity (LMA) and immediate early gene (IEG) induction in the rat using two routes of drug administration, intraperitoneal (i.p.) and subcutaneous (s.c.). Adult male rats received saline or PCP (1.0-5.0 mg/kg) either i.p or s.c. and were assessed for LMA for 60 min. At the end of...

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 1, 2008 Lêda S B Garcia, Clarissa M Comim, Samira S Valvassori et al.

Ketamine is a non-competitive antagonist to the phencyclidine site of N-methyl-d-aspartate (NMDA) receptor. Clinical findings point to a rapid onset of action for ketamine on the treatment of major depression. Considering that classic antidepressants may take long-lasting time to exhibit their main therapeutic effects, the present study aims to compare the behavioral effects and the BDNF...

Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters.

Progress in Neuro-Psychopharmacology and Biological Psychiatry June 30, 2007 Jean-Philippe Marquis, Marie-Claude Audet, François Y Doré et al.

The cognitive effects of subchronic phencyclidine administration in rats are still unsettled in the literature. Possible causes of discrepancies are different drug treatment regimens and task parameters. The current experiment tested whether variations in procedures of the delayed T-maze alternation task result in performance differences following identical PCP treatments. Sixteen rats were...

Rewarding effects of 3,4-methylenedioxymethamphetamine ("Ecstasy") in dominant and subordinate OF-1 mice in the place preference conditioning paradigm.

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 30, 2007 G Rodriguez-Alarcón, J J Canales, A Salvador

We tested the ability of 3,4-methylenedioxymethamphetamine (MDMA) to induce conditioned place preference (CPP) in dominant and subordinate OF-1 mice subjected to cohabitation and repeated sessions of agonistic confrontation, as well as in non-confronted mice. We selected doses of MDMA (2, 6, 10 mg/kg) previously reported to induce CPP in mice and we measured expression of c-Fos evoked by the...

Combined intoxication with methylone and 5-MeO-MIPT

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 30, 2006 Eiji Shimizu, Hiroyuki Watanabe, Takashi Kojima et al. 103 citations

Although preclinical studies suggest that methylone (2-methylamino-1-[3,4-methylenedioxyphenyl]propan-1-one) and 5-MeO-MIPT (5-methoxy-N-methyl,N-isopropyl tryptamine) may have psychostimulant properties, the scientific reports about the clinical effects of these agents are scant. We describe a 27-year-old male patient with substance intoxication after a single ingestion of the mixture of...

DOI: 10.1016/j.pnpbp.2006.06.012 (opens in new tab) Designer drug Mephedrone Hallucinogen Ingestion +1

Effect of Zen Meditation on serum nitric oxide activity and lipid peroxidation.

Progress in Neuro-Psychopharmacology and Biological Psychiatry February 1, 2005 Do-Hoon Kim, Yoo-Sun Moon, Hee-Sung Kim et al.

This study was designed to investigate the effect of Zen Meditation on serum nitric oxide activity (NO) and oxidative stress (lipid peroxidation). The experimental group included 20 subjects who had practiced the Zen Meditation program in Meditation Center located in Seoul, South Korea. The control group included 20 subjects who did not practice any formal stress management technique and were...

Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.

Progress in Neuro-Psychopharmacology and Biological Psychiatry August 1, 2003 Mirna Bainy Leal, Kátia Michelin, Diogo Onofre Souza et al. 50 citations

Ibogaine (IBO) is an alkaloid with putative antiaddictive properties, alleviating opiates dependence and withdrawal. The glutamate N-methyl-D-aspartate (NMDA) receptors have been implicated in the physiological basis of drug addiction; accordingly, IBO acts as a noncompetitive NMDA antagonist. The purpose of this study was to evaluate the effects of IBO on naloxone-induced withdrawal syndrome...

DOI: 10.1016/s0278-5846(03)00109-x (opens in new tab) Full text (opens in new tab) Ibogaine Psychoactive alkaloid Morphine withdrawal Opioid withdrawal +13

Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.

Progress in Neuro-Psychopharmacology and Biological Psychiatry February 1, 2002 Linda A Parke, Page Burton, Robert V Mcdonald et al. 17 citations

It has been reported that ibogaine interferes with somatic withdrawal reactions in rats chronically treated with morphine. The present experiments demonstrated that ibogaine also interferes with motivational withdrawal reactions and somatic withdrawal reactions in rats treated with morphine on only two occasions. On each of two conditioning trials, naloxone was administered 24 h following an...

Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.

Progress in Neuro-Psychopharmacology and Biological Psychiatry April 2001 E D O'Loinsigh, G Boland, J P Kelly et al.

1. The ability of N-ethyl (MDEA) and N-butyl (MDBA) analogues of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') to induce acute behavioural changes and increases in body temperature, and to cause serotonergic neurotoxicity, was assessed in young adult male Wistar rats. The in vitro ability of MDMA analogues to evoke presynaptic monoamine release from crude rat forebrain synaptosomal...

Further investigations of the serotonergic properties of the ibogaine-induced discriminative stimulus.

Progress in Neuro-Psychopharmacology and Biological Psychiatry February 1, 1999 Scott Helsley, R A Rabin, Jerrold C Winter 9 citations

1. 5-HT3, 5-HT2C, and 5-HT1A receptor ligands were assessed in rats trained to discriminate ibogaine from water. 2. Significant ibogaine-appropriate responding was observed following treatment with the 5-HT2C agonists MK-212 (79.6%) and mCPP (76.4%). This substitution was completely antagonized by metergoline, an agent with 5-HT2C antagonist properties. However, metergoline was ineffective...

DOI: 10.1016/s0278-5846(98)00101-8 (opens in new tab) Full text (opens in new tab) Ibogaine's unique cue Ibogaine's effects Full ibogaine experience Ibogaine's characteristic stimulus +14

A comparison of N,N-dimethyltryptamine, harmaline, and selected congeners in rats trained with LSD as a discriminative stimulus

Progress in Neuro-Psychopharmacology and Biological Psychiatry May 1, 1998 Scott Helsley, David Fiorella, Richard A. Rabin et al. 30 citations

1. A series of N-substituted tryptamines was compared with a series of beta-carbolines in rats trained to discriminate LSD (0.1 mg/kg) from saline. 2. Intermediate levels of substitution were elicited by MDMT (76.4%), DMT (77.9%), and DET (48.7%). 6-F-DET produced 41.3% LSD-appropriate responding at a dose of 6.0 mg/kg but only 4 of 8 subjects completed the test session thus precluding...

DOI: 10.1016/s0278-5846(98)00031-1 (opens in new tab) Tryptamines Harmaline Hallucinogen Stimulus generalization +1

Actions of methoxylated amphetamine hallucinogens on serotonergic neurons of the brain.

Progress in Neuro-Psychopharmacology and Biological Psychiatry August 1996 N J Penington

1. Previous studies of phenethylamine hallucinogenic drugs have reported that intravenous injection of DOI or similar compounds produce an inhibition of the firing rate of serotonergic dorsal raphe neurons of the rat; potentially lowering levels of 5-HT throughout the brain. 2. Direct application by iontophoresis demonstrated only weak non-specific effects, but injection into the nucleus...

Ibogaine fails to interrupt the expression of a previously established one-trial morphine place preference.

Progress in Neuro-Psychopharmacology and Biological Psychiatry July 1, 1996 Tracey Luxton, Linda A. Parker, S Siegel 13 citations

1. Ibogaine, a proposed anti-addictive agent, has been found to interfere with the acquisition of a weak morphine-induced place preference. The present series of experiments determined if ibogaine would interfere with the expression of a previously established morphine (5 mg/kg) place preference. 2. A single injection of 40 mg/kg of ibogaine 24 h, 12 h or 4 h prior to the preference test...

Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.

Progress in Neuro-Psychopharmacology and Biological Psychiatry November 1995 R S Cohen

1. The objective of this paper was to provide an understanding of methylenedioxymethamphetamine (MDMA) use. This investigation provides the subjective effects that were reported by MDMA users. 2. There were a total of (500) humans who participated in this study. 3. Using a survey device, data from users were collected. Symptomatology associated with both the consumption of MDMA and its residual...

Diazepam antagonizes effects on dopamine metabolism produced by PCP receptor agonists.

Progress in Neuro-Psychopharmacology and Biological Psychiatry March 1, 1992 M. Bowers, J. B. Morton

1. Male rats were injected with either saline, diazepam, MK-801, or diazepam plus MK-801. 2. In previous work with phencyclidine (PCP), diazepam significantly reduced the increase in homovanillic acid (HVA) in olfactory tubercle and prefrontal cortex. 3. Diazepam also lowered the HVA increase following MK-801 in caudate, olfactory tubercle, and prefrontal cortex. 4. Benzodiazepine receptors may...

An EEG and behavioural study on the interactions of clonidine with phencyclidine and ketamine in rats.

Progress in Neuro-Psychopharmacology and Biological Psychiatry 1990 P Popoli, A Pezzola, A Scotti de Carolis

1. Clonidine, an alpha-2 adrenergic agonist, induced in rats a synchronization of the electrical activity of the brain (EEG) accompanied by sedation starting from the dose of 0.05 mg/kg, i.p. 2. This drug (0.05 mg/kg, i.p.) was also able to influence both the EEG and behavioural effects elicited by two "dissociative anaesthetics", PCP and KT. 3. At low and moderate doses of these two drugs,...

LSD and other related hallucinogens elicit myoclonic jumping behavior in the guinea pig.

Progress in Neuro-Psychopharmacology and Biological Psychiatry 1989 P Carvey, P Nausieda, R Weertz et al.

1. We evaluated the behavioral response of guinea pigs to hallucinogenic agents in order to characterize the response of this species to a variety of known hallucinogenic drugs. 2. The systemic injection of LSD in the guinea pig elicited a "myoclonic-like" response the frequency of which was dose-dependent. This behavior exhibited rapid tolerance which was more prominent at higher doses. 3....

Pentobarbital-like electroencephalographic rubral rhythm induced by ketamine in rabbits.

Progress in Neuro-Psychopharmacology and Biological Psychiatry 1989 S Sagratella, A Scotti de Carolis

1. The effects caused by the dissociative anaesthetic drugs (PCP, KT), the sigmaopiates (SKF 10.047, cyclazocine), and the mixed excitatory amino acid antagonist CCP on the electrical activity of the red nucleus in rabbits were compared with PB. 2. Ketamine (10 mg/kg, i.v.) induced the appearance of a pentobarbital-like EEG synusoidal rhythm characterized by an increase in amplitude and a...